祥生医疗
(688358)
| 流通市值：32.52亿 | | | 总市值：32.52亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,016,854,712.62 | 985,616,661.93 | 951,228,143.05 | 942,834,475.81 |
| 应收票据及应收账款 | 182,887,395.62 | 161,693,930.83 | 180,033,703.05 | 176,028,703.49 |
| 应收账款 | 182,887,395.62 | 161,693,930.83 | 180,033,703.05 | 176,028,703.49 |
| 预付款项 | 5,341,722.15 | 3,545,925.97 | 5,126,773.84 | 7,352,623.96 |
| 其他应收款合计 | 2,882,721.23 | 2,442,579.31 | 2,491,645.31 | 4,158,885.8 |
| 存货 | 107,496,307.15 | 126,328,601.45 | 135,933,909.68 | 119,771,387.66 |
| 其他流动资产 | 5,463,996.32 | 10,235,745.55 | 14,763,543.84 | 10,814,952.44 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,426,068,834.92 | 1,405,034,429.79 | 1,409,841,502.17 | 1,416,233,030.98 |
| 非流动资产: | | | | |
| 固定资产 | 73,009,334.41 | 76,314,597.43 | 76,852,533.07 | 75,431,680.06 |
| 在建工程 | 83,408,289.08 | 76,304,572.93 | 56,607,614.14 | 56,899,296.62 |
| 使用权资产 | 4,512,454.21 | 5,104,235.25 | 5,749,876.45 | 6,516,355.64 |
| 无形资产 | 20,207,244.37 | 20,430,187.86 | 20,653,143.46 | 20,876,083.86 |
| 长期待摊费用 | 825,138.44 | 881,009.06 | 926,666.2 | 1,180,612.91 |
| 递延所得税资产 | 8,380,795.03 | 8,450,807.75 | 8,554,338.45 | 9,382,963.93 |
| 其他非流动资产 | 5,478,231.4 | 4,489,927.55 | 7,500,066.16 | 9,002,431.83 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 195,821,486.94 | 191,975,337.83 | 176,844,237.93 | 179,289,424.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,621,890,321.86 | 1,597,009,767.62 | 1,586,685,740.1 | 1,595,522,455.83 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 91,195,788.33 | 96,283,693.04 | 94,390,666.32 | 77,219,229.41 |
| 其中：应付票据 | 29,534,690.37 | 15,300,677.94 | 1,713,701.83 | 623,848.17 |
| 应付账款 | 61,661,097.96 | 80,983,015.1 | 92,676,964.49 | 76,595,381.24 |
| 合同负债 | 27,168,696.75 | 30,704,100.11 | 17,055,428.9 | 22,714,399.31 |
| 应付职工薪酬 | 9,819,871.45 | 18,727,016.72 | 16,052,116.8 | 13,314,420.74 |
| 应交税费 | 11,229,323.9 | 8,234,926.03 | 5,192,105.09 | 9,781,288.5 |
| 其他应付款合计 | 6,777,977.06 | 8,943,895.83 | 63,594,781.57 | 95,395,203.98 |
| 应付股利 | - | - | 57,456,000 | 89,499,802.4 |
| 一年内到期的非流动负债 | 3,137,370.2 | 3,859,872.88 | 4,052,349.05 | 4,000,554.07 |
| 其他流动负债 | 38,199.42 | 31,871.96 | 14,838.53 | 20,283.33 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 149,367,227.11 | 166,785,376.57 | 200,352,286.26 | 222,445,379.34 |
| 非流动负债: | | | | |
| 租赁负债 | 2,589,665.85 | 2,667,633.99 | 3,361,495.67 | 4,327,318.86 |
| 预计负债 | 7,046,212.09 | 6,162,274.31 | 5,260,158.51 | 4,779,773.49 |
| 递延收益 | 667,218.25 | 807,928.7 | 1,973,337.44 | 2,042,815.96 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 10,303,096.19 | 9,637,837 | 10,594,991.62 | 11,149,908.31 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 159,670,323.3 | 176,423,213.57 | 210,947,277.88 | 233,595,287.65 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 112,124,537 | 112,124,537 | 112,124,537 | 112,124,537 |
| 资本公积 | 904,345,150.81 | 903,807,703.65 | 906,308,445.25 | 906,231,787.39 |
| 减:库存股 | 10,094,650.08 | 10,094,650.08 | 10,094,650.08 | 10,094,650.08 |
| 其他综合收益 | 1,185,051.52 | 1,703,584.49 | -3,548,659.06 | -218,387.44 |
| 盈余公积 | 56,062,268.5 | 56,062,268.5 | 56,062,268.5 | 56,062,268.5 |
| 未分配利润 | 398,597,640.81 | 356,983,110.49 | 314,886,520.61 | 297,821,612.81 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,462,219,998.56 | 1,420,586,554.05 | 1,375,738,462.22 | 1,361,927,168.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,462,219,998.56 | 1,420,586,554.05 | 1,375,738,462.22 | 1,361,927,168.18 |
| 负债和股东权益合计 | 1,621,890,321.86 | 1,597,009,767.62 | 1,586,685,740.1 | 1,595,522,455.83 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-31 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |